Period 3

DRUG2 trials

Sponsors

Pfizer, Daewoong Pharmaceutical Co. LTD.

Conditions

Healthy VolunteersTTR Cardiomyopathy

Phase 1

A Study To Determine Any Effect Of Tafamidis On Electrocardiographic Intervals, Specifically The Rate Corrected QT Interval (QTc)

CompletedNCT01775761

PfizerTTR Cardiomyopathy

Start: 2013-01-31End: 2013-04-30Updated: 2013-05-21

Bioepuivalence Study for the Safety and the Pharmacokinetics of DWJ1589 and DWC202315

Not yet recruitingNCT06592495

Daewoong Pharmaceutical Co. LTD.Healthy Volunteers

Start: 2024-10-31End: 2025-10-31Target: 52Updated: 2024-09-23